| human | Q5 |
| P496 | ORCID iD | 0000-0002-7041-7755 |
| P1053 | ResearcherID | J-2888-2015 |
| P108 | employer | Milan Polyclinic | Q1413761 |
| P734 | family name | Moia | Q58455257 |
| Moia | Q58455257 | ||
| Moia | Q58455257 | ||
| P735 | given name | M. | Q19803510 |
| M. | Q19803510 | ||
| P106 | occupation | researcher | Q1650915 |
| Q80543384 | A commentary: to screen for calf DVT or not to screen? The highly variable practice among Italian centers highlights this important and still unresolved clinical option. Results from the Italian MASTER registry |
| Q53198183 | A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program. |
| Q46401127 | A multicentre randomised clinical endpoint study of PARMA 5 computer-assisted oral anticoagulant dosage. |
| Q81302804 | An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage |
| Q38300336 | Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis. |
| Q84377198 | Biological variation of INR in stable patients on long-term anticoagulation with warfarin |
| Q71264573 | Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy |
| Q33357198 | Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures. |
| Q47958105 | Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry. |
| Q45866004 | Comments on: Laboratory tests for the management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants: proposals of the Working Group on Perioperative Haemostasis (GIHP). |
| Q70339571 | Correction of the bleeding time in treated patients with severe von Willebrand disease is not solely dependent on the normal multimeric structure of plasma von Willebrand factor |
| Q44092654 | Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms. |
| Q83460782 | Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities |
| Q43248351 | Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis |
| Q81404812 | Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry |
| Q83826092 | False-negative or false-positive: laboratory diagnosis of lupus anticoagulant at the time of commencement of anticoagulant: a rebuttal |
| Q44518926 | Heparin-induced thrombocytopenia and warfarin-induced skin necrosis in a child with severe protein C deficiency: successful treatment with dermatan sulfate and protein C concentrate. |
| Q73794520 | Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation |
| Q33366745 | Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study |
| Q40841012 | Laboratory measures of hemostasis for monitoring liver graft function. |
| Q45862044 | Laboratory tests during direct oral anticoagulant treatment |
| Q84126230 | Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registry |
| Q84419887 | More on: new antithrombotics: a need for laboratory monitoring. For or against |
| Q71112355 | Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry |
| Q45868646 | New oral anticoagulants in thrombotic antiphospholipid syndrome. |
| Q53338757 | Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study. |
| Q46929690 | Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different INR targets. |
| Q43484026 | Prevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the Master Registry |
| Q37554153 | Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention |
| Q78605515 | Prevention of edema, flight microangiopathy and venous thrombosis in long flights with elastic stockings. A randomized trial: The LONFLIT 4 Concorde Edema-SSL Study |
| Q51821178 | Prevention of venous thrombosis with elastic stockings during long-haul flights: the LONFLIT 5 JAP study. |
| Q45870409 | Prognostic value of the activated partial thromboplastin time after orthotopic liver transplantation. A prospective study. |
| Q63247719 | Prognostic value of the activated partial thromboplastin time after orthotopic liver transplantation: a prospective study |
| Q83270851 | Renal allograft thrombosis |
| Q33735241 | Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies |
| Q43590683 | Risk factors for venous thromboembolism in the elderly: results of the master registry |
| Q62618731 | The LONFLIT4-Concorde Deep Venous Thrombosis and Edema Study: Prevention with Travel Stockings |
| Q73018553 | The LONFLIT4-Concorde--Sigvaris Traveno Stockings in Long Flights (EcoTraS) Study: a randomized trial |
| Q80783848 | The MASTER registry on venous thromboembolism: description of the study cohort |
| Q53125685 | The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation. |
| Q51822485 | The cost-effectiveness of computer-assisted anticoagulant dosage: results from the European Action on Anticoagulation (EAA) multicentre study. |
| Q57194100 | The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism |
| Q53850167 | Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment. |
| Q28192428 | Venous thrombosis from air travel: the LONFLIT3 study--prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial |
| Q44604258 | Warfarin and acenocoumarol dose requirements according to CYP2C9 genotyping in North-Italian patients. |
Search more.